New drugs 06, part I.
Hussar
Daniel A
DA
Philadelphia College of Pharmacy, University of the Sciences, Philadelphia, PA, USA.
D000077443:Acamprosate; D000227:Adenine Nucleotides; D000427:Alcohol Deterrents / Q000627:therapeutic use; D000682:Amyloid / Q000627:therapeutic use; D018712:Analgesics, Non-Narcotic / Q000627:therapeutic use; D019380:Anti-HIV Agents / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects; D052157:Aptamers, Nucleotide / Q000627:therapeutic use; D001087:Arabinonucleosides / Q000627:therapeutic use; D053961:Azabicyclo Compounds; D001572:Benzofurans / Q000627:therapeutic use; D000077866:Clofarabine; D017277:Drug Approval; D004358:Drug Therapy / Q000451:nursing / Q000639:trends*; D064420:Drug-Related Side Effects and Adverse Reactions; D054714:Echinocandins; D000077270:Exenatide; D051523:Fibroblast Growth Factor 7 / Q000627:therapeutic use; D006147:Guanine / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D058228:Islet Amyloid Polypeptide; D055666:Lipopeptides; D008074:Lipoproteins / Q000627:therapeutic use; D008268:Macular Degeneration; D000077551:Micafungin; D010353:Patient Education as Topic; D010455:Peptides / Q000627:therapeutic use; D010456:Peptides, Cyclic / Q000627:therapeutic use; D010879:Piperazines / Q000627:therapeutic use; D011759:Pyrrolidines / Q000627:therapeutic use; D011812:Quinuclidines / Q000627:therapeutic use; D000069464:Solifenacin Succinate; D013280:Stomatitis / Q000139:chemically induced / Q000188:drug therapy; D013654:Taurine / Q000031:analogs & derivatives / Q000627:therapeutic use; D044005:Tetrahydroisoquinolines / Q000627:therapeutic use; D014549:Urinary Incontinence / Q000188:drug therapy; D014688:Venoms / Q000627:therapeutic use; D020960:omega-Conotoxins / Q000627:therapeutic use
D000227:Adenine Nucleotides; D000427:Alcohol Deterrents; D000682:Amyloid; D018712:Analgesics, Non-Narcotic; D019380:Anti-HIV Agents; D000935:Antifungal Agents; D000970:Antineoplastic Agents; D052157:Aptamers, Nucleotide; D001087:Arabinonucleosides; D053961:Azabicyclo Compounds; D001572:Benzofurans; D054714:Echinocandins; D007004:Hypoglycemic Agents; D058228:Islet Amyloid Polypeptide; D055666:Lipopeptides; D008074:Lipoproteins; D010455:Peptides; D010456:Peptides, Cyclic; D010879:Piperazines; D011759:Pyrrolidines; D011812:Quinuclidines; D044005:Tetrahydroisoquinolines; D014688:Venoms; D020960:omega-Conotoxins; C515050:zopiclone; D051523:Fibroblast Growth Factor 7; D013654:Taurine; C495058:pegaptanib; C413685:entecavir; D006147:Guanine; D000077866:Clofarabine; C078452:ziconotide; D000077270:Exenatide; C101207:darifenacin; C105254:pramlintide; D000069464:Solifenacin Succinate; D000077443:Acamprosate; D000077551:Micafungin